WallStSmart

Kenvue Inc. (KVUE)vsVital Farms Inc (VITL)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Kenvue Inc. generates 1891% more annual revenue ($15.12B vs $759.44M). KVUE leads profitability with a 9.7% profit margin vs 8.7%. VITL trades at a lower P/E of 8.4x. VITL earns a higher WallStSmart Score of 69/100 (B-).

KVUE

Buy

58

out of 100

Grade: C

Growth: 4.7Profit: 6.5Value: 4.7Quality: 4.5
Piotroski: 3/9Altman Z: 1.22

VITL

Strong Buy

69

out of 100

Grade: B-

Growth: 9.3Profit: 7.0Value: 8.3Quality: 8.0
Piotroski: 2/9Altman Z: 5.64
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

KVUESignificantly Overvalued (-15.9%)

Margin of Safety

-15.9%

Fair Value

$16.00

Current Price

$17.53

$1.53 premium

UndervaluedFair: $16.00Overvalued
VITLUndervalued (+38.0%)

Margin of Safety

+38.0%

Fair Value

$41.61

Current Price

$13.65

$27.96 discount

UndervaluedFair: $41.61Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

KVUE0 strengths · Avg: 0/10

No standout strengths identified

VITL6 strengths · Avg: 9.3/10
P/E RatioValuation
8.4x10/10

Attractively priced relative to earnings

EPS GrowthGrowth
51.3%10/10

Earnings expanding 51.3% YoY

Altman Z-ScoreHealth
5.6410/10

Safe zone — low bankruptcy risk

Return on EquityProfitability
21.4%9/10

Every $100 of equity generates 21 in profit

Debt/EquityHealth
0.179/10

Conservative balance sheet, low leverage

Price/BookValuation
1.7x8/10

Reasonable price relative to book value

Areas to Watch

KVUE3 concerns · Avg: 3.0/10
Revenue GrowthGrowth
3.2%4/10

3.2% revenue growth

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Altman Z-ScoreHealth
1.222/10

Distress zone — elevated risk

VITL3 concerns · Avg: 2.7/10
Market CapQuality
$518.47M3/10

Smaller company, higher risk/reward

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

Free Cash FlowQuality
$-32.15M2/10

Negative free cash flow — burning cash

Comparative Analysis Report

WallStSmart Research

Bull Case : KVUE

PEG of 1.48 suggests the stock is reasonably priced for its growth.

Bull Case : VITL

The strongest argument for VITL centers on P/E Ratio, EPS Growth, Altman Z-Score. Revenue growth of 28.7% demonstrates continued momentum.

Bear Case : KVUE

The primary concerns for KVUE are Revenue Growth, Piotroski F-Score, Altman Z-Score.

Bear Case : VITL

The primary concerns for VITL are Market Cap, Piotroski F-Score, Free Cash Flow.

Key Dynamics to Monitor

KVUE profiles as a value stock while VITL is a growth play — different risk/reward profiles.

VITL carries more volatility with a beta of 1.35 — expect wider price swings.

VITL is growing revenue faster at 28.7% — sustainability is the question.

KVUE generates stronger free cash flow (744M), providing more financial flexibility.

Bottom Line

VITL scores higher overall (69/100 vs 58/100) and 28.7% revenue growth. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Kenvue Inc.

CONSUMER DEFENSIVE · HOUSEHOLD & PERSONAL PRODUCTS · USA

Kenvue Inc. is a consumer health company globally.

Visit Website →

Vital Farms Inc

CONSUMER DEFENSIVE · FARM PRODUCTS · USA

Vital Farms, Inc., an ethical food company, offers free range products in the United States. The company is headquartered in Austin, Texas.

Visit Website →

Want to dig deeper into these stocks?